Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
US7541477B2 · kind B2 · utility
2Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2003 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Mar 13, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a benzimidazole derivative of the general formula [I][wherein B1, B2, and B3 represent hydrogen atom or lower alkyl; R1 and R2 are same or different and represent lower alkyl, etc.; R3 and R4 represent hydrogen atom, etc.; W represents a 3 to 8-membered aromatic or alphatic heterocycle, etc.; and Ar represents a substituted or unsubstituted aromatic heterocycle, etc.] This compound functions as an antagonist to melanin-concentrating hormone receptor and is useful as a drug for central diseases, circulatory diseases and metabolic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.